Sutures Are Losing Ground. Medtronic Is Positioned to Profit.
Bio-synthetic adhesives are entering human trials, and the surgical sealant market is set to get more competitive.
Bio-synthetic adhesives are entering human trials, and the surgical sealant market is set to get more competitive.
The acquisition of Onnec repositions CBRE well beyond real estate services, but the deal size barely moves the needle for…
Raytheon's defense booking machine is running at full speed, but Q3 asks whether the engine can keep converting orders into…
With personal-injury claims still unresolved and the Solventum stake swinging reported earnings, income investors need to look past the headline…
A $4 billion contracted plant outside AEP's service territory is a new kind of utility growth, and Bloom Energy is…
An MSCI governance shock shows how thin liquidity can break.
Eight months of shooting in the Strait of Hormuz, record backlogs, and shares still well below their March highs. The…
Most Western investors cannot buy in directly. But India funds may already own exposure, and the listing could shift index…
Eight straight sessions wiped 15.7% from the SOX and handed short sellers $32 billion. The broader market barely flinched —…
Industrial up ~30%, data center doubling. EPS seen at $2.42 as TXN pulls back from $334.